Medical Xpress October 31, 2024
Hebrew University of Jerusalem

A recent study has developed a novel method to analyze genetic variations in families with a high incidence of breast cancer. By examining 1,218 genetic variants in 12 families, the research identified 80 genes linked to an increased risk of the disease. It also highlighted the significant—yet previously overlooked—roles of peroxisomal and mitochondrial pathways in breast cancer predisposition and patient survival.

Breast cancer is the most common malignancy among Western women, with up to 10% of cases attributed to genetic variants. Despite this, the roots of many familial cases remain unexplored, largely due to the complex nature of the genetic factors involved.

Addressing this critical gap, a recent study led by Prof. Dina Schneidman-Duhovny from the Rachel and Selim Benin...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Pharma / Biotech, Precision Medicine, Survey / Study, Technology, Trends
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health
Oncologist talks personalized medicine for pancreatic cancer
AI offers a step above genomic solutions
How Mayo Clinic is using real-world data to advance precision medicine
Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Share This Article